# Deloreanai

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/deloreanai
- **Dataset:** https://optimly.ai/brand/deloreanai.json
- **Markdown:** https://optimly.ai/brand/deloreanai/llms.txt
- **Official website:** https://deloreanai.com
- **Slug:** deloreanai
- **Categories:** ai-machine-learning, healthcare-it

## Overview

- **Tagline:** The first AI biologically validated by multiple independent 3rd party labs, achieving 85-87% prediction accuracy. Deployed at 14 clients, including a Fortune 5 healthcare organization, significantly reducing medical loss ratio and enhancing care quality.
Source: Brand's website (https://deloreanai.com) · 2026-10-04

- **Description:** DeLorean AI provides a predictive medical AI platform, MARTI, that leverages advanced insights to proactively manage and mitigate health risks, prevent disease progression, reduce hospitalizations, and lower costs for insurers and care providers.
Source: Brand's website (https://deloreanai.com) · 2026-10-04

## Offerings

- **Core capabilities:**
  - MARTI Medical AI
  - offering five specialized care modules for renal disease
  - diabetes
  - cardiovascular disease
  - behavioral health
  - and respiratory disease.
Source: Brand's website (https://deloreanai.com) · 2026-10-04

- **Pricing:** Value-based model, likely subscription-based, tied to cost savings (e.g., reducing medical loss ratio by as much as $100 PMPM) and improved patient outcomes.
Source: Brand's website (https://deloreanai.com) · 2026-10-04

## Audience

- **Target industry:** Insurers and care providers, including Fortune 5 healthcare organizations.
Source: Brand's website (https://deloreanai.com) · 2026-10-04

Page last updated 2026-10-17.